The Association of Fenofibrate and The Risk of Retinopathy in Type 2 Diabetes

ASIAIR > College of Computer Science > Department of Biomedical informatics > Theses & dissertations > Item 310904400/12786

Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/12786

Title:	The Association of Fenofibrate and The Risk of Retinopathy in Type 2 Diabetes
Authors:	Fitri, Sulidar
Contributors:	Department of Biomedical informatics Yu - Ching, Chen
Keywords:	Retinopathy;Type II Diabetes;National Health Insurance Database
Date:	2012
Issue Date:	2012-11-18 09:33:41 (UTC+0)
Publisher:	Asia University
Abstract:	Retinopathy is the most common complication in type 2 diabetes. Many people usually will get diabetic retinopathy when they have diabetic type 2. In Taiwan the incidence of type 2 diabetes is high, so the retinopathy prone to happen in these persons and finally might lead to blindness in the productive age. Fenofibrate is a drug for lipid control by lowering the lipid. In this research, based on the data from National Health Insurance Research Database, I study the association of using fenofibrate and the risk of retinopathy in type 2 diabetes. The results are significant because 95%CI does not include 1 and the HR is less than one, so the risk of retinopathy is low. From adjusted variable of gender (HR=0.82; 95%CI= 0.71-0.95), age (HR=0.81; 95%CI= 0.70-0.94), sex and age (HR=0.81; 95%CI= 0.70-0.94) and for not adjusted variable it obtained (HR=0.82; 95%CI= 0.71-0.95).
Appears in Collections:	[Department of Biomedical informatics ] Theses & dissertations

Files in This Item:

File	Description	Size	Format
index.html		0Kb	HTML	607	View/Open